Detalhe da pesquisa
1.
Comparative study of the efficacy and safety of secukinumab vs ixekizumab in moderate-to-severe psoriasis after 1 year of treatment: Real-world practice.
Dermatol Ther
; 33(3): e13313, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181962
2.
Ixekizumab for Patients with Plaque Psoriasis Affected by Multiple Sclerosis: Case report.
Sultan Qaboos Univ Med J
; 21(3): 488-490, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522419